The high blood pressure drug fimasartan, an Ang II receptor antagonist, also ameliorates zebrafish models of heart failure, normalizing the expression of atrial natriuretic peptide, reducing cell death around the heart, and improving blood flow (Quan et al., 2020). The gene discussed is NPPA; the disease is heart failure.